38 related articles for article (PubMed ID: 30041718)
1. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.
Zhou Y; Wang S; Ying X; Wang Y; Geng P; Deng A; Yu Z
Int J Nanomedicine; 2017; 12():6153-6168. PubMed ID: 28883726
[TBL] [Abstract][Full Text] [Related]
2. A Y
Wang Y; Jiang Z; Yuan B; Tian Y; Xiang L; Li Y; Yang Y; Li J; Wu A
Biomater Sci; 2019 Nov; 7(11):4748-4757. PubMed ID: 31508613
[TBL] [Abstract][Full Text] [Related]
3. A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells.
Baek JS; Cho CW
Oncotarget; 2017 May; 8(18):30369-30382. PubMed ID: 28423731
[TBL] [Abstract][Full Text] [Related]
4. A simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistance.
Li J; Xu R; Lu X; He J; Jin S
Int J Nanomedicine; 2017; 12():8043-8056. PubMed ID: 29138561
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and bioactivity evaluation of novel indole-selenide derivatives as P-glycoprotein inhibitors against multi-drug resistance in MCF-7/ADR cell.
Yang Z; Luo D; Shao C; Hu H; Yang X; Cai Y; Mou X; Wu Q; Xu H; Sun X; Wang H; Hou W
Eur J Med Chem; 2024 Mar; 268():116207. PubMed ID: 38364715
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers.
Yu J; Hu F; Zhu Q; Li X; Ren H; Fan S; Qian B; Zhai B; Yang D
Nanoscale Res Lett; 2020 Mar; 15(1):59. PubMed ID: 32166458
[TBL] [Abstract][Full Text] [Related]
7. Engineering extracellular vesicles mimetics for targeted chemotherapy of drug-resistant ovary cancer.
Liu X; Liu G; Mao Y; Luo J; Cao Y; Tan W; Li W; Yu H; Jia X; Li H
Nanomedicine (Lond); 2024 Jan; 19(1):25-41. PubMed ID: 38059464
[TBL] [Abstract][Full Text] [Related]
8. A multifunctional poly(curcumin) nanomedicine for dual-modal targeted delivery, intracellular responsive release, dual-drug treatment and imaging of multidrug resistant cancer cells.
Wang J; Wang F; Li F; Zhang W; Shen Y; Zhou D; Guo S
J Mater Chem B; 2016 May; 4(17):2954-2962. PubMed ID: 27152196
[TBL] [Abstract][Full Text] [Related]
9. Cationic pillar[6]arene/ATP host-guest recognition: selectivity, inhibition of ATP hydrolysis, and application in multidrug resistance treatment.
Yu G; Zhou J; Shen J; Tang G; Huang F
Chem Sci; 2016 Jul; 7(7):4073-4078. PubMed ID: 30155051
[TBL] [Abstract][Full Text] [Related]
10. Discovery of new tricyclic spiroindole derivatives as potent P-glycoprotein inhibitors for reversing multidrug resistance enabled by a synthetic methodology-based library.
Yu T; Zeng R; Guan Y; Pan B; Li HW; Gu J; Zheng PF; Qian Y; Ouyang Q
RSC Med Chem; 2024 May; 15(5):1675-1685. PubMed ID: 38784466
[TBL] [Abstract][Full Text] [Related]
11. Reversing Anticancer Drug Resistance by Synergistic Combination of Chemotherapeutics and Membranolytic Antitumor β-Peptide Polymer.
Shao N; Yuan L; Liu L; Cong Z; Wang J; Wu Y; Liu R
J Am Chem Soc; 2024 Apr; ():. PubMed ID: 38602146
[TBL] [Abstract][Full Text] [Related]
12. Retraction Note: Co-delivery of doxorubicin and SIS
Wang S; Tan X; Zhou Q; Geng P; Wang J; Zou P; Deng A; Hu J
Drug Deliv Transl Res; 2024 Jul; 14(7):2019. PubMed ID: 38051476
[No Abstract] [Full Text] [Related]
13. Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma-A Narrative Review.
Luo Y; Sun M; Tan L; Li T; Min L
Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140058
[TBL] [Abstract][Full Text] [Related]
14. Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review.
Mir SA; Hamid L; Bader GN; Shoaib A; Rahamathulla M; Alshahrani MY; Alam P; Shakeel F
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235145
[TBL] [Abstract][Full Text] [Related]
15. Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer.
Benko A; Medina-Cruz D; Vernet-Crua A; O'Connell CP; Świętek M; Barabadi H; Saravanan M; Webster TJ
Cancer Drug Resist; 2021; 4(2):264-297. PubMed ID: 35582024
[TBL] [Abstract][Full Text] [Related]
16. miR-21 Induces Chemoresistance in Ovarian Cancer Cells via Mediating the Expression and Interaction of CD44v6 and P-gp.
Wang Y; Chen G; Dai F; Zhang L; Yuan M; Yang D; Liu S; Cheng Y
Onco Targets Ther; 2021; 14():325-336. PubMed ID: 33469309
[TBL] [Abstract][Full Text] [Related]
17. Overcoming Biological Barriers With Block Copolymers-Based Self-Assembled Nanocarriers. Recent Advances in Delivery of Anticancer Therapeutics.
Torres J; Dhas N; Longhi M; García MC
Front Pharmacol; 2020; 11():593197. PubMed ID: 33329001
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression.
Lu YL; Ma YB; Feng C; Zhu DL; Liu J; Chen L; Liang SJ; Dong CY
J Cancer; 2019; 10(10):2357-2368. PubMed ID: 31258739
[TBL] [Abstract][Full Text] [Related]
19. Folate-Targeted Redox-Responsive Polymersomes Loaded with Chemotherapeutic Drugs and Tariquidar to Overcome Drug Resistance.
Qin Y; Zhang Z; Huang C; Fan F; Liu L; Lu L; Wang H; Liu Z; Yang J; Wang C; Yang H; Sun H; Leng X; Kong D; Zhang L; Zhu D
J Biomed Nanotechnol; 2018 Oct; 14(10):1705-1718. PubMed ID: 30041718
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
